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Saposin B (Sap B) is an essential activator protein for arylsulfatase A in the hydrolysis of sulfatide, a lipid component ofmyelin. To study
Sap B’s role in hearing and balance, a Sap B-deficient (B/) mouse was evaluated. At both light and electron microscopy (EM) levels,
inclusion body accumulation was seen in satellite cells surrounding spiral ganglion (SG) neurons from postnatal month 1 onward,
progressing into large vacuoles preceding satellite cell degeneration, and followed by SG degeneration. EM also revealed reduced or
absent myelin sheaths in SG neurons from postnatal month 8 onwards. Hearing loss was initially seen at postnatal month 6 and pro-
gressed thereafter for frequency-specific stimuli, whereas click responses became abnormal from postnatal month 13 onward. The
progressive hearing loss correlated with the accumulation of inclusion bodies in the satellite cells and their subsequent degeneration.
Outer hair cell numbers and efferent function measures (distortion product otoacoustic emissions and contralateral suppression) were
normal in the B/mice throughout this period. Alcian blue staining of SGs demonstrated that these inclusion bodies corresponded to
sulfatide accumulation. In contrast, changes in the vestibular system were much milder, but caused severe physiologic deficits. These
results demonstrate that loss of Sap B function leads to progressive sulfatide accumulation in satellite cells surrounding the SG neurons,
leading to satellite cell degeneration and subsequent SG degeneration with a resultant loss of hearing. Relative sparing of the efferent
auditory and vestibular neurons suggests that alternate glycosphingolipid metabolic pathways predominate in these other systems.
Key words: auditory; cochlea; prosaposin; saposin B; spiral ganglion; sulfatide
Introduction
Saposins (Sap) are a family of four small glycoproteins, termed
Sap A–D, that are generated in lysosomes from a single precursor
protein, prosaposin (Kishimoto et al., 1992). Genetic deficiencies
of individual Saps or the precursor prosaposin lead to lysosomal
storage diseases, highlighting their physiological importance in
glycosphingolipid (GSL) degradation (Hulkova´ et al., 2001;Mat-
suda et al., 2004). Each of the four Saps is necessary for the activity
of one or more lysosomal GSL hydrolases (Sun et al., 2002).
Sap B is a nonenzymatic GSL activator protein that has lipid
transfer properties (Ciaffoni et al., 2006) and stimulates the deg-
radation of sulfatide, a major lipid component of myelin, as well
as other glycolipids (Li et al., 1988). Sap B facilitates partial ex-
traction of target GSLs from membranes, forming soluble pro-
tein–lipid complexes and presenting them to arylsulfatase A
(ASA) and -galactosidase A, respectively, for cleavage (Ahn et
al., 2003).
Loss of ASA activity leads to the human disease metachro-
matic leukodystrophy (MLD), characterized by accumulation of
sulfatides, progressive demyelination, and extensive whitematter
damage (Von Figura et al., 2001). In mice, targeted disruption of
ASA results in diminished in vivo enzyme activity, a resulting
accumulation of sulfatide in white matter, and a neurological
phenotypewithout demyelination, including deafness, thatman-
ifests by 24 months of age [postnatal month 24 (P24mo); Hess et
al., 1996].
Sap B deficiency in humans, caused by a cysteine mutation on
Sap B, has been reported in 10 patients involving the fifth cysteine
in the Sap B domain. This mutation leads to elevated sulfatide
levels in the kidneys and brain, with variable neurological pheno-
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types (Sandhoff, 2001), and a MLD-like disease similar to that
observed with ASA deficiency, with lysosomal storage of cerebro-
side sulfate (Schlote et al., 1991). These mutations include sub-
stitutions for critical cysteine residues, insertions, transversions
or obliteration of a glycosylation site (Deconinck et al., 2008).
Hearing loss and vestibular dysfunction in patients with variant
form MLD have not been documented.
A mouse model of Sap B deficiency was previously generated
by introducing a point mutation into the Sap B domain of pro-
saposin, destroying one of the three essential disulfide bonds of
Sap B (Sun et al., 2008). This mutation led to an unstable and
undetectable Sap B protein, but preserved prosaposin and Sap A,
C, and D processing and function. Similar to human patients
(Sandhoff, 2001), these Sap B/ mice mimicked the biochem-
istry and phenotype of the human disease and developed neuro-
logical impairment, including ataxia, head tremor, impaired
neuromotor coordination, and neuronal storage of sulfatide in
their auditory neurons (Sun et al., 2008). However, in contrast to
the detailed study of hearing in ASA-deficient mice, no detailed
study has been reported of the effect of this Sap Bmutation on the
hearing and balance in Sap B-deficientmice. The objective of this
report is thus to fully characterize the auditory phenotype in the
Sap B/ mouse, providing insight into Sap B’s role in hearing
and balance, and also to assess possible differences in function
between ASA and Sap B.
Materials andMethods
Animals
C57BL/6J Sap B KO (B/) mice were provided by Dr. Gregory A.
Grabowski of the Cincinnati Children’s Hospital Medical Center, Cin-
cinnati, Ohio, and backcrossed to an FVB (Friend leukemia virus, strain
B) strain (a strain with minimal auditory deficits) to the 10 th generation.
These mice are termed B/ (sapBC240F/C240F) and Het (sapBC240F/wt).
Both males and females were randomly used on all experiments. The
general and CNS phenotype of this B/ mouse have been previously
described (Sun et al., 2008). All procedures and animal handling were
done according to approved national ethical guidelines and complied
with all protocol requirements of the University of California San Fran-
cisco Institutional Animal Care and Use Committee.
Auditory testing
Hearing tests were performed as previously described (Akil et al., 2006)
with the B/mice, heterozygote (Het), and wild-type (WT) littermates
at different ages (P1mo–P15mo). Briefly, all auditory testing was per-
formed in a sound-proof chamber. Before acoustic testing, mice were
anesthetized by intraperitoneal injection of amixture of ketamine hydro-
chloride (Ketaset, 100 mg/ml) and xylazine hydrochloride (xyla-ject, 10
mg/ml) and boosted with one-fifth the original dose as required. Body
temperature was maintained with a heating pad and monitored with a
rectal probe throughout recording.
Auditory brainstem response. The evoked acoustic brainstem response
(ABR) thresholds were differentially recorded from the scalp of themice.
Responses were recorded using subdermal needle electrodes at the ver-
tex, below the pinna of the left ear (reference), and below the contralat-
eral ear (ground). The sound stimuli used included clicks (5ms duration,
31 Hz) and tone pips at 8, 16, and 32 kHz (10ms duration, cos2 shaping,
21 Hz). Measurements were recorded using the TDT BioSig III system
(Tucker Davis Technologies). For each stimulus, electroencephalo-
graphic (EEG) activity was recorded for 20 ms (at a sampling rate of 25
kHz) and filtered (0.3–3 kHz). Waveforms from 512 stimuli were aver-
aged for click responses.Waveforms from1000 stimuli were examined to
identify frequency-specific tone-burst stimuli (8, 16, and 32 kHz). ABR
waveforms were recorded in 5 dB sound pressure level (SPL) intervals
down from the maximum amplitude. The threshold was defined as the
lowest stimulus level at which response peaks for waves I–V were clearly
and repetitively present upon visual inspection. These threshold judg-
ments were confirmed by analysis of stored waveforms. Data were ob-
tained from the WT (n  15), B/ (n  10), and Het (n  12) mice
littermates.
The comparison of each group of animals was performed using one-
way ANOVAwith Bonferroni’s post hoc testing. Significance was defined
at p 0.05. To compare the change of ABR latencies, the ABR peaks and
troughs were identified automatically by cursers programmed to identify
each peak using the Tucker-Davis Technologies system software, and
then verified by visual inspection of the recorded wave forms. Latencies
were calculated from the onset of the stimulus, and the interpeak latency
calculated by subtraction of wave II-I (P2  P1). The change of the
interpeak latency was then calculated. Due to the reduction in the audi-
tory neurons, wave I amplitude analysis was done by peak-to-peak mea-
surement at different intensity levels (86, 76, 66, and 56 dB SPL) of the
stored click ABR waveforms.
Distortion product otoacoustic emissions. The distortion product otoa-
coustic emissions (DPOAEs) were measured using an acoustic probe
placed in the left external auditory canal. Stimuli consisted of two pri-
mary tones (f1/f2 1.25) digitally synthesized at 100 kHz using SigGen
software. The primary tones with geometric mean (GM) frequencies
ranging from 6 to 32 kHz and with equal levels (L1 L2 60 dB SPL)
were presented via two separate speakers (EC1; Tucker Davis Technolo-
gies) to the acoustic probe. DPOAE 2f1-f2 responses were recorded using
an ER-10B (Etymotics Research) microphone assembly within the
acoustic probe and the Tucker Davis Technologies BioSig III system.
Responses were amplified, digitally sampled at 100 kHz, and averaged
over 50 discrete spectra. Fast Fourier transforms were computed from
averaged responses. For each stimulus set, the DPOAE amplitude level at
2f1-f2 was extracted, and SPLs for data points 100 Hz above and below
the DPOAE frequency were averaged for the noise floor measurements.
DPOAE levels were plotted as a function of primary tone GM frequency.
Statistical analysis was done using ANOVA with Bonferroni’s post hoc
tests with significance defined as p 0.05. Data were collected frommice
at varying ages, including P4moandP8mo forWT (n 6), B/ (n 9),
and Het (n 8) mice.
Contralateral suppression of DPOAEs. Contralateral suppression of
DPOAEs (CS-DPOAEs) was performed using the same software as pre-
viously described (Jacobson et al., 2003) with different GM frequencies
ranging from 8 to 32 kHz. Stimuli were digitally synthesized at 200 kHz
using SigGen software applications with the ratio of frequency 2 (F2) to
frequency 1 (F1) constant at 1.25; L1 was equal to 65 dB SPL and L2 was
equal to 55 dB SPL as calibrated in a 0.1ml coupler simulating themouse
ear canal. Wide-band noise synthesized by the Tucker Davis Technolo-
gies Real-Time Processor Video Design Studio software module was set
to 55 dB SPL for each mouse. Stimulus probe and microphone were
placed in the test ear or the coupler and the speaker for the contralateral
noise source was placed into the opposite ear canal close to the tympanic
membrane. Three to four different trials of DPOAEs were acquired and
gathered under two different stimulus conditions: in quiet and with con-
tralaterally applied wideband noise. Contralateral suppression magni-
tude was defined and calculated as distortion product level with
contralateral noise-distortion product level in quiet and negative values
indicate efferent suppression. Three to four different sets of test results
for each animal were averaged and used for statistical difference analysis
between WT (n  6), B/ (n  9), and Het (n  8) mice littermates
using either Student’s t test or Mann–Whitney test with significance
defined as p 0.04.
Cochlea section immunofluorescence
B/ and WT mice littermates at P6mo were anesthetized and their
cochleae were isolated, dissected, perfused through the oval and round
windows by 4%paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB),
pH 7.4, and incubated in the same fixative for 2 h. After fixation, cochleae
were rinsed with PB and immersed in 5% EDTA in 0.1 M PB for decalci-
fication. When cochleae were totally decalcified (2–3 d), they were incu-
bated overnight in 30% sucrose for cryoprotection. The cochleae then
were embedded in O.C.T. Tissue Tek Compound (Miles Scientific). Tis-
sues were cryosectioned parallel to the modiolus at 10–12 m thickness
for immunofluorescence and for alcian blue stain, mounted on Super-
frost microscope slides (Erie Scientific), and stored at20°C until use.
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For immunofluorescent staining of B/ and WT cochlea sections, a
rabbit anti-neurofilament-200 polyclonal antibody (NF-200; Millipore
Bioscience Research Reagents), which labels afferent and efferent audi-
tory fibers (Berglund and Ryugo, 1991), was used in this study. After
incubation at 37°C for 30 min, the sections were rinsed twice for 10 min
in 0.1 M PBS, pH 7.4, and then preincubated for 1 h in a humid chamber
with blocking buffer and then incubated overnight at 4°C with the pri-
mary antibody NF-200 diluted in the blocking buffer to 1:500. The slides
were then rinsed (twice for 10 min) and incubated for 2 h in goat anti-
rabbit IgG conjugated to Cy2 diluted to 1:2000. Following the removal of
the secondary antibodies and before the final washes, the sections were
exposed for 15 min at room temperature to a fluorescent dye 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI; 1.5 g/ml in PBS;
Sigma-Aldrich). DAPI staining enabled visualization of the nuclei to-
gether with immunofluorescence. The sections were rinsed in PBS (twice
for 10 min) and mounted in equal parts glycerol/PBS and coverslipped.
The slides were then observed with an Olympus microscope with confo-
cal immunofluorescence.
Cochlea whole-mount immunofluorescence
B/mouse cochleae were perfused with 4% PFA in 0.1 M PBS, pH 7.4,
and kept in the fixative for 2 h at 4°C. Cochleae were washed with PBS
three times for 10 min and then decalcified with 5% EDTA in 0.1 M PBS
for 2 d. Following decalcification, the otic capsule was then removed,
followed by removal of the lateral wall, Reissner’s membrane, and the
tectorial membrane. The remaining organ of Corti was incubated with
the anti-myosin VIIa antibody (a hair-cell-specific marker; 1:50 dilution
in PBS; Proteus Biosciences, catalog #25-6790) and incubated overnight
at 4°C. Whole-mount cochleae were rinsed twice for 10 min with PBS
and then incubated for 2 h with a goat anti-rabbit IgG antibody conju-
gated to Cy2 (1:2000 dilution in PBS; Jackson ImmunoResearch, 111-
165-003). The whole mounts were rinsed in PBS twice for 15 min and
incubated with rhodamine–phalloidin (stock solution of 200 U/ml
methanol, diluted 1:100 in PBS for working solution) for 1 h. Whole
mounts were then rinsed with PBS, further microdissected into individ-
ual turns for surface preparation, and then exposed for 15 min at room
temperature to the fluorescent DAPI to mark nuclei. The cochlear whole
mounts were rinsed in PBS and mounted on glass slides in antifade
FluorSave reagent (Calbiochem, 34589). Hair cells in the organ of Corti
were visualized under a confocal microscope.
Vestibular testing
Vestibular evoked potential. Vestibular evoked potential (VsEP) record-
ings were based on the methods published previously (Jones et al., 1999,
2004;Mock et al., 2011) and are briefly described here. Animals (P15mo;
B/, n  3; WT, n  5) were anesthetized with a ketamine/xylazine
(18:2 mg/ml) mixture, 7 l per gram body weight, injected intraperito-
neally. Core body temperature was maintained at 37.0  0.2°C using a
homoeothermic heating pad system (FHC). Vestibular stimuli were de-
livered by securing the mouse head using a noninvasive head clip to a
mechanical shaker (Model ET-132-203, Labworks). Linear acceleration
pulses (17 pulses/s, 2 ms duration) ranging from 6 to 18 dB re: 1.0
g/ms (where 1 g 9.8m/s 2), adjusted in 3 dB steps were presented to the
head in the naso-occipital axis. Subcutaneous needle electrodes were
placed posterior to the right pinna and at the right hip for inverting and
ground electrodes, respectively. Stainless-steel wire placed subcutane-
ously at the nuchal crest served as the noninverting electrode. Electroen-
cephelographic activity was amplified (200,000), filtered (300–3000
Hz), and digitized (1024 points at 10 s/point). Two hundred fifty-six
primary responses were averaged and replicated for each VsEP wave-
form. A VsEP intensity series was collected beginning at the maximum
stimulus level (i.e.,6 dB re: 1.0 g/ms) with and without acoustic mask-
ing (50–50,000Hz forwardmasker at 90 dB SPL), and then descending in
3 dB steps until no response was visible. Thresholds (measured in dB re:
1.0 g/ms), peak latencies (milliseconds), and peak-to-peak amplitudes
(microvolts) were obtained from the VsEP waveforms.
Swimming test. Vestibular function was also assessed with the com-
monly used test, the swimming test. The data of the swimming test (Lim
et al., 1978; Sawada et al., 1994;Ornitz et al., 1998; Jones et al., 1999; Khan
et al., 2004) were obtained from 6WT and 6 B/mice at different ages
(P4mo, P8mo, and P15mo).Micewere put in a 20 40 cmPlexiglas cage
filled with water at room temperature for 60 s. The average swimming
time with the head above water was determined for three trials for each
mouse.
Alcian blue staining
Alcian blue stain, which detects acidic sulfated lipids, was used to dem-
onstrate sulfatide accumulation in cochlea sections. B/ and WTmice
littermates at P6mo were anesthetized and their cochleae were processed
for frozen sections as described above. Sections were rinsed in 3% acetic
acid for 3min and stainedwith alcian blue solution (1%alcian blue in 3%
acetic acid), pH 2.5 (Polyscientific, S111A), for 30min. After rinsingwith
3% acetic acid followed by water, sections were counterstained with nu-
clear fast red; slides were then mounted and visualized with a Leica
microscope.
Histology
Light microscopy. B/ mice and WT littermates at different ages
(P1mo–P15mo) were anesthetized and their cochleae were isolated, dis-
sected, perfused through the round and oval windows with a solution of
2.5% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M PB solution,
pH 7.4, and finally incubated in the same fixative overnight at 4°C. The
cochleae were rinsed with 0.1 M PB and postfixed in 1% osmium tetrox-
ide for 2 h. The cochleae were subsequently immersed in 5% EDTA for
decalcification. The decalcified cochleae were dehydrated with ethanol
and propylene oxide and then embedded in Araldite 502 resin (Electron
Microscopy Sciences). The cochleae were then sectioned at 1–5 m
thickness parallel to the cochleamodiolus. The sectionswere stainedwith
toluidine blue andmountedwith Permount (Fisher Scientific) onmicro-
scope slides and visualized with a Leica microscope.
EM. The cochleae of B/ and WT mice were surgically exposed, a
stapedectomy was performed, and the round window perforated. Tem-
poral bones were preserved by gentle in vivo perfusion of fixative (2.5%
paraformaldehyde and 1.5% glutaraldehyde buffered to pH 7.4 with 0.1
M phosphate) through the perilymphatic channels, followed by postfix-
ation with a solution of 1% osmium tetroxide and 1.5% potassium fer-
ricyanide phosphate buffered solution (potassium ferricyanide was used
to improve contrast). The cochleae were decalcified, dehydrated, and
then embedded in Epon. Thick sections (1m)weremounted onto glass
slides and counterstained with toluidine blue. Once the cochlea spiral
ganglion (SG) cells were observed, several ultrathin silver-to-gray sec-
tions were collected on Formvar films on slotted grids and stained with
saturated aqueous 2% uranyl acetate and 0.4% lead citrate in 0.15N
sodium hydroxide. The stained sections were then examined at 60 kV in
a JEOL JEM-100S transmission electron microscope.
Cochlea SG cell counts. Cochlea SG cells numerical density assessment
was calculated as described by Leake et al. (2011) to accurately estimate
the number of nuclei in a given volume of tissue. For this analysis, three
sets of three serial sections (5mthickness) were collected from the base,
midturn, and the apex of 4 WT and 5 B/ cochlea. Adjacent serial
sections were compared, and newnuclei of SG neurons that appear in the
second section were counted. Statistical differences weremeasured using
Student’s t test.
Sulfatide and ceramide analysis using liquid chromatography/
tandem mass spectrometry
Synthetic N-acyl ceramide standards (C16, C17, C18, C24 Cer) of 99%
purity were from Avanti Lipids. Semisynthetic N-acyl sulfatides (C12,
C16, C24 sulfatide) were fromMatreya. All other solvents and chemicals
of either high-performance liquid chromatography grade or analytical
purity were purchased from Sigma-Aldrich. Mouse cochlea SGs dis-
sected from P6mo cochleae of WT and B/ mice were homogenized
with PowerGen 35 (Fisher Scientific) inmethanol/chloroform/water (3.6
ml, 2:1:0.6, v/v/v). Homogenates were shaken for 15min and centrifuged
(5min at 1000 g). Pellets were re-extracted withH2O (0.7ml) and 3ml
of chloroform/methanol (1:2). The combined extracts were centrifuged
(10 min at 7000  g). The supernatants were transferred to fresh tubes
and the solvents evaporated under nitrogen gas. Dried samples were then
dissolved in chloroform/methanol/water (5 ml, 2:1:0.15) and subjected
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to alkaline methanolysis followed by eluting from a Sephadex G-25 fine
column to remove nonlipid contaminants. The extracted lipids were
suspended inmethanol containing internal standards for liquid chroma-
tography/mass spectrometry analyses.
Nonhydroxy fatty acid (NFA) sulfatide, hydroxy fatty acid (HFA) sul-
fatide, and ceramide were determined by liquid chromatography–electros-
pray ionization–tandem mass spectrometry using a Waters Quattro Micro
API triple quadrupole mass spectrometer interfaced with Acquity UPLC
system. Online chromatographic separation was achieved using a Thermo
Scientific BetaSil C8 column (100 2.1 mm, 5 m). The electrospray ion-
ization–tandemmass spectrometry was performed in themultiple-reaction
monitoring mode. Sulfatides were analyzed in negative ion mode by detec-
tion of their parent ion and common daughter ion of m/z 97. Ceramides
were detected with the transition pair of the individual protonated parent
ions and their common daughter ion m/z 264. Optimized parameters for
each lipid were determined with individual standard compounds. C16 and
C24 sulfatide standards were used to construct calibration curves and C12
sulfatide was used as an internal standard. For ceramide analysis, C16, C18,
and C24 ceramides were used for calibration curves and C17 ceramide was
used as the internal standard.
Results
Light microscopy
Standard histological analysis was initially used to assess the re-
sult from the loss of Sap B function in the B/ mouse ears. As
expected, inWT control midmodiolar sections, SG neurons were
present in normal numbers throughout the cochlea and their
light microscopic appearance was unremarkable (Fig. 1A–D,
white arrows). In B/ mice, the morphology of the organ of
Corti was for themost part normal across all genotypes, including
normal inner hair cells (IHCs), outer hair cells (OHCs), tectorial
membrane, and stria vascularis (Fig. 1A,B). The most significant
finding in the cochleae of B/mice was a severe reduction of SG
neurons and cochlear nerve fibers within Rosenthal’s canal (Fig.
1A). The degeneration was notable by P8mo and progressed
through P15mo (Fig. 1C). Closer examination at varying time
points, including at P1mo, P2mo, P4mo, P6mo, P8mo, and
P15mo demonstrated abnormal inclusion in the B/ satellite
cells adjacent to the SG neurons in Rosenthal’s canal (Fig. 1C,
black arrows). These inclusions in the satellite cells become visi-
ble as early as P1mo in B/mice and increase dramatically with
age. In oldermice, they can also be seen in the cytoplasmof the SG
neuronal cell bodies. These increases in severity of the inclusion
bodies are closely associated with the loss of SG neurons in the
B/mouse at P6mo and beyond. By P15mo, the inclusions are
greater while the SG cell numbers are severely reduced. The only
surviving neurons in the older B/ mice proved to be small,
primarily nonmyelinated type 2 ganglion cells. The small diame-
ter and the absence of a compact myelin sheath served to identify
the surviving neurons as type 2 cells (Fig. 1C, P15mo, arrow-
heads). Figure 1D shows higher-magnification images of the SG
cells of normal satellite cells in theWTand increasing inclusion in
the satellite cells in the B/mice.
SG neuronal analysis
At several developmental stages, transverse cochlea sections of
WT mice show a normal number of myelinated nerve fibers
within the osseous spiral lamina while sections of B/ mouse
cochlea show a progressive loss of nerve fibers (Fig. 2A). This loss
of fibers in the B/mice was further confirmed by immunoflu-
orescence staining of the cochlea cross sections (Fig. 2B) using an
anti-neurofilament antibody, amarker of both afferent and effer-
ent neuronal auditory nerves (Berglund andRyugo, 1991), which
demonstrates weaker signal in the B/ mouse compared with
the WT mouse.
To quantitatively assess the loss of cochlear neuron fibers,
counts were made in tangentially sectioned specimens at the co-
chlea midturn during development (Fig. 2C) in the same region
of the cochlea where the transverse cochlea sections were made
(Fig. 2A). The average number of myelinated nerves in this spe-
cific region was calculated in 100 m segments. These counts
demonstrate that the loss of cochlear nerve fibers in the B/
mice begins at P4mo and progresses through P15mo where only
43 and 15% of nerve fibers remain, respectively (Fig. 2D). The
cochlear Schwann cell counts were done in a similar manner and
confirm that the loss of cochlear neuronal fibers is accompanied
by the loss of Schwann cells (Fig. 2E). SG cell numerical density,
calculated as described by Leake et al. (2011), documents that the
total cochlear SG cell loss is similar to the cochlea nerve fiber loss
in B/ mice, but is variable between cochlea turns (Fig. 2F):
more SG cell loss was seen in the base at P4mo compared with
midturns and apical turns. Interestingly, though the overall num-
ber of SG neurons was reduced in B/ mice, there was a clear
increase in the size of individual SG neurons at all ages in the apex
and at P15mo for all cochlea turns (Fig. 2G).
EM
At the ultramicroscopic level, the changes in the SG neurons were
even more striking (Fig. 3). As compared with WTmouse SG neu-
rons (Fig. 3A), B/mouse SG neurons demonstrated marked hy-
pertrophy and accumulation of clear vacuoles in the satellite cells
(appearing like fatty particles), resulting in disruption of the normal
structure of the SG. Similar to that seen under light microscopy,
these inclusions in the satellite cells increased progressively with age
and were highly associated with the loss of SG neurons in the B/
mouse. By P15mo, the SG neurons were severely reduced in the
B/mouse. SGneuronal organelles otherwise appear normal. The
myelin sheaths of the cochlear nerve fibers were also analyzed (Fig.
3B). As shown, by P8mo and onward, there was almost a complete
lack of myelin surrounding these neurons, suggesting either a cause
or consequence of the SG neuronal degeneration.
Auditory measures
We next sought to determine the effect of Sap B deficiency on
hearing in light of the progressive neuronal degeneration seen in
this model. In these studies, ABR was used to test hearing in
B/, Het, and WT mice at varying ages (P1mo, P3mo, P4mo,
P6mo, P8mo, P13mo, and P15mo) using broadband clicks and
tone-burst stimuli (8, 16, and 32 kHz). As shown in Figure 4A, at
P4mo, ABR thresholds demonstrated no significant differences
in hearing among the B/ (n 10), Het (n 12), andWTmice
(n  15). However by P8mo (Fig. 4B) a significant increase in
ABR thresholds was observed for each of the tone-burst stimuli
(8, 16, and 32 kHz), though not for click stimuli, in B/ mice
compared with WT and Het mice. For click stimuli, the thresh-
olds of WT versus B/ mice did not significantly differ until
P13mo (Fig. 4C). In contrast, for pure-tone stimuli, significant
threshold shifts are seen as early as P6mo (Fig. 4D; only the 16
kHz tone is shown). We also noted that at P4mo there was no
significant difference of the ABR wave I amplitude between
B/ and theWTmice for click stimulus (data not shown). By
P8mo, however, B/ mice showed a significant decrease of
ABR amplitude when compared with the WT littermates (Fig.
4E), likely as a consequence of the reduction in the auditory
neurons.
To analyze whether the demyelination of cochlear fibers seen
at the EM level (Fig. 3B) affectedABRwavemorphology, the ABR
interpeak latency between P1 and P2 was measured at varying
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Figure 1. Light microscopy of the cochlea and SG neurons of B/mice during development. A, B, Cochlea and organ of Corti at low (A) and high (B) magnification. Rosenthal’s canal (RC) is
occupied by SG cells and cochlear nerve fibers in theWT (shownat P15mo),while similar views of the B/mouse aremarkedby increasing loss of SG and cochlear nerve fibers at P8moandP15mo.
These imagesalsodocumentnormal organof Cortimorphology, including IHCsandOHCsand the stria vascularis inbothWTandB/mice throughP15mo.NF,Nerve fibers; TC, tunnel of Corti. Scale
bar, 200 m. C, Light micrographs of semithin sections (5 m) of SGs of B/ mice at P1mo, P2mo, P4mo, P6mo, P8mo, and P15mo. WT mice at P1mo, P6mo, and P8mo are included for
comparison. Overall morphology between the SGs of the B/ and the WT mice is similar, but abnormal inclusions in the satellite cells are first seen at P1mo in B/mice (black arrow) when
comparedwith normal SGs ofWT (white arrow)mice. These inclusions in the satellite cells increase progressivelywith age (arrows) and are associatedwith loss of SGneurons in B/mice at P6mo
and older. At P15mo, nonmyelinated SG type 2 neurons are clearly visualized and normal appearing (arrowheads), whereas myelinated type 1 neurons SG cell numbers are severely
reduced in B/mice. Scale bar, 10m. D, Magnified view of the SG neurons and surrounding normal satellite cells in WT mice (white arrows) and increasing inclusions in the satellite
cells in B/ mice (black arrows).
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Figure 2. Cochlea SG neurons and nerve fiber assessment in the B/mice during development.A, Toluidine blue-stained sections of the radial cochlea nerve fibers during development stages
show a progressive cochlea fiber loss with age in the B/micewhen comparedwith theWT littermates (black arrows). Scale bar, 30m.B, Immunofluorescence of the cochlea nerve fibers with
anti-neurofilament antibody (amarker of afferent and efferent neuronal auditory nerves; Berglund and Ryugo, 1991) stain shows that the P6moB/mouse cochlear section has significantly less
labelingof thecochlearnerve fibers comparedwith theWT littermate,documenting thepresenceof fewer fibers in theB/ comparedwith theWTmice. Scalebar, 50m.C, Toluidineblue-stainedsections,
cut tangentially through the osseous spiral lamina to reveal cochlear nerve fibers in cross section, show a progressive cochlear fiber loss with age in B/mice comparedwithWT littermates, similar to that
observedfortheradialcochleanervefibers in lightmicroscopy(A)andimmunofluorescence(B).Scalebar,10m.D,Quantitativeassessmentofcochleanervefibernumbers inB/miceduringdevelopment.
Lossofnervefibers is firstdocumentedatP4moandincreasedatP8moandP15mo,whenonly43and15%ofnervefibers remain, respectively.E, ThecochlearSchwanncell countsweredone inasimilarmanner
andconfirmthat the lossof cochlearneuronal fibers is accompaniedby the lossof Schwanncells atP8moandatP15mo inB/mice.F, Quantitativeassessmentof cochleaSGcell counts throughP15mo. The
lossofcochlearSGneuronsmirrorsthelossofcochleanervefibersinB/mice.AtP4mo,therewasagreaterlossofSGneuronsinthebasecomparedwiththemidturnsandapicalturns,butbyP8moandbeyond
nodifferences incellcountswerenotedbetweenturns.G,ThoughoverallSGneuronalcounts,Schwanncells,andnervefibersarereduced(Fig.2D–F ), theSGcellsizewassignificantly increasedintheapicalturns
andmidturns of B/mice at P4moandP8mo, but at P15mo this increase in cell sizewas significant for all cochlear turns.
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time points. At P4mo, no significant differences in P2-P1 laten-
cies were seen between B/ andWTmice for either tone or click
stimuli (data not shown). By P8mo however, B/mice demon-
strated significant P2-P1 delays for tone stimuli, though not for
click stimuli (Fig. 4F). This decrease in conductionvelocity is likely a
consequence of the progressive SGdemyelination and/or SGneuro-
nal degeneration in B/mice evident at this time period.
OHC and efferent function of the Sap B mice
DPOAE and CS tests were performed to evaluate the OHC and
efferent neuronal function in B/mice at P4mo (Fig. 5A,C)
and P8mo (Fig. 5B,D). As shown in Figure 5A–D, no signifi-
cant differences were noted between B/ and WT mice
DPOAE and CS at P4mo and P8mo, excluding the impair-
ments that are due to a peripheral loss of hair cell function that
Figure3. EMof the SGneurons and themyelin sheaths of B/mice.A, SG neurons fromWT (P8mo) andB/ (P8moandP15mo)mice at lowermagnification. Scale bars: top, 2m;bottom,
1m.WTmice demonstrate normal SGmorphology (left column). In contrast, inclusions were seen in B/mouse ears where satellite cells are packed with lucent material containing inclusion
bodies with large vacuolesmixedwith large electron densematerial. These inclusions in the satellite cells greatly increase in B/mice at P15mo. The separation of themyelin sheath from the SG
neuron seen inWTmice is likely artifactual, due to specimen processing. N, SG nucleus; SC, satellite cells; SC I, satellite cells plus inclusions; black arrows, inclusions in SG cytoplasm. B, At P8mo,
SG myelin sheaths in B/mice are so thin they seem to disappear. Meanwhile, SG myelin sheaths in the WT littermates at P8mo are clearly visible. Scale bar, 300 nm.
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would also affect the general neuronal output. At P8mo, B/ co-
chlear whole mounts of the base, midturn, and apex stained with
myosin 7a, amarker for hair cells, demonstratednormal numbers of
OHCs. Additional labeling with phalloidin, a stain for actin, also
revealed that OHC stereocillia and cuticular plates were present
and intact (Fig. 5E). Based upon these results, there does not
appear to be a defect in OHC or efferent function through P8mo,
despite the loss of	50% of the SG neurons at this same age.
Vestibular analysis
To investigate whether the degenerative changes observed in
the cochlea also affected the vestibular system, Scarpa’s gan-
glia and the vestibular fibers of the crista ampullaris (ampulla)
were similarly studied at various ages and compared with WT
littermates. The overall appearance and organization of the
B/ ampulla appeared unaltered, including normal hair cells
and supporting cell numbers and appearance, with no notice-
able vestibular fiber loss in older ages when compared with
WT littermates (Fig. 6A). At P15mo, at a time when significant
loss of SG neurons is evident, there is very little loss of vestib-
ular nerve fibers, despite the presence of inclusion bodies (Fig.
6A, black arrows). Figure 6B demonstrates that similar inclu-
sion bodies observed in SGs were also observed in Scarpa’s
ganglia of the B/mouse, though not nearly as dramatic and
causing significantly less damage.
To test whether these modest histologic changes resulted in
any functional loss, the swim test was used to measure the ability
of the B/ mouse to orient in a head-up position and swim
Figure 4. ABRmeasurement of B/mice. ABRwas used to test hearing in B/, Het, andWTmice at varying ages (P1mo, P3mo, P4mo, P6mo, P8mo, P13mo, and P15mo) using broadband
clicks and tone-burst stimuli (8, 16, and 32 kHz). A, At P4mo, ABR thresholds demonstrate no significant differences in hearing between the B/ (n 10), Het (n 12), andWT (n 15) mice.
B, At P8mo, significant increases in the ABR threshold for each of the tone-burst stimuli (8, 16, and 32 kHz) are noted, though click responses are not significantly different at this age. C, There are
no differences seen in click stimuli between WT and B/ mice until P13mo. Afterward the B/ auditory thresholds become significantly elevated. D, In contrast to click stimuli, the
frequency-specific ABR thresholds are significantly elevated at P6mo and older for each of the sound stimuli (8, 16, and 32 kHz; only 16 kHz is shown). E, There is a significant decrease in ABRwave
I amplitudes in theB/micemeasured at different intensity levels (86, 76, 66, and56dBSPL)when comparedwith theWT littermates (Fig. 4E), likely as a consequence of the reduction in auditory
neurons. F, ABR P2–P1interpeak latencies showed a small but significant increase at P8mo between B/ andWTmice.
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comfortably for a full 60 s (data not shown; Sawada et al., 1994).
All B/ mice were able to swim and orient properly in water,
indistinguishable from WT mice, and able to keep their heads
above water for the full 60 s during all three trials.
More detailed analysis of the vestibular system was obtained
by studying VsEPs. Interestingly, despite the modest histologic
changes and normal swim test, Figure 6C,D shows that the re-
sponses were completely absent from all B/ mice that were
tested. No measurable responses were observed even at the high-
est stimulus level (6 dB re: 1.0 g/ms). In contrast, normal ves-
tibular function was observed in WT mice as expected. The
control group had a mean VsEP threshold of9.3 1.5 dB (re:
1.0 g/ms), P1 peak latency of 1.36 0.03 ms, and P1-N1 ampli-
tude of 0.65 0.07 V. Together, these results demonstrate that
B/mice present a significant vestibular dysfunction caused by
the degeneration of the Scarpa’s ganglion neurons and the ves-
tibular nerve fibers.
Sulfatide analysis
Alcian blue stain, which detects acidic sulfated lipids, was used
to assess sulfatide accumulation in cochlear sections of the
B/ andWT littermates. This test has previously been shown
to be abnormal in other organs of B/mice (Sun et al., 2008).
In the cochlea of B/ mice, a significant increase in alcian
blue staining was noted in the SGs (Fig. 7A), indicative of
sulfatide accumulation. Further analysis of sulfatide accumu-
lation was performed by liquid chromatography/tandemmass
spectrometry (Fig. 7B–E). For these studies, SG neurons
within Rosenthal canals from P6mo B/ and WT mice were
pooled for lipid extraction and analysis. Levels of most NFA
sulfatide and HFA sulfatide (Fig. 7B) species significantly in-
creased in B/ mouse SGs compared with WT mouse SGs.
Both the total NFA sulfatide and HFA sulfatide levels in-
creased in B/mouse SGs by 1.74-fold and 1.44-fold, respec-
tively, compared with the WT mouse SGs. On the other hand,
total ceramide levels (Fig. 7C) showed no significant increase
in the B/ SGs when compared with the WT SGs. When
sulfatide levels were normalized by C18 ceramide in the same
sample (Fig. 7D,E), NFA sulfatide species increased dramati-
cally by 3.5-fold. Total sulfatide levels in B/ SGs increased
by 1.65-fold compared with WT SGs, consistent with the in-
creased alcian blue staining seen in SG cochlea sections (Fig.
7A).
Figure 5. OHC and efferent function of B/mice. A–E, OHC and efferent auditory function in B/mice were measured using DPOAE (A, B), CS-DPOAE (C, D), and cochlear whole-mount
immunofluorescent staining using anti-myosin 7a antibody and rhodamine phalloidin staining (E). At P4mo, DPOAE (A) and CS-DPOAE (C) demonstrate no significant differences betweenWT and
B/mice. Likewise, at P8mo, no differences are noted in these measures in WT and B/mice (B, D). E, Hair cell counts using representative samples of surface preparations show a normal
complement of OHC and no OHC loss at all locations along the cochlea. Scale bar, 20m. OHC rows 1–3 are indicated by OHC1, OHC2, and OHC3, respectively.
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Discussion
This study demonstrates that absence of Sap B function in the
inner ear results in progressive accumulation of sulfatides in the
satellite cells surrounding SG neurons, followed by degeneration
of the satellite cells and loss of the myelin sheath surrounding the
type I SGneurons, and finally death of the SGneurons themselves
with a resulting loss of hearing. Histological evidence of the SG
degeneration is seen as early as P4mo, but becomes much more
evident at P8mo and beyond (Fig. 1A). The vestibular system,
while still demonstrating sulfatide accumulation, has a milder
phenotypewith less neuronal loss but severe physiologic dysfunc-
tion as demonstrated by absent VsEPs. This represents a marked
difference compared with the severe changes seen in the prosa-
posin KOmouse (Akil et al., 2006), which demonstrated normal
SG cell counts, deafness by P25mo, and death by P30mo.
A central feature of the degeneration was the progressive ac-
cumulation of inclusion bodies in the satellite cells surrounding
the SG neurons, visible from P1mo onwards. These included
NFA sulfatides and HFA sulfatides, intermediate metabolites of
GSL processing (Fig. 7). In the GSL-degradation pathway, cer-
amides are derived from sphingomyelin, glucosylceramide, and
galactosylceramide that is downstream from sulfatide. Accumu-
Figure 6. Vestibular function in B/ mice. A–D, Light microscopy of the ampullae nerve fibers (A), vestibular ganglion neurons (B), and the VsEP recordings (C, D) of B/ mice during
development. A, The general organization of the ampulla appears unaltered (normal hair cell and supporting cell morphology) with no noticeable vestibular fiber loss in B/mice at older ages
when comparedwithWTmice. At P8mo–P15mo, inclusion bodies are seen (black arrows) though there is not an accompanying loss of vestibular neurons. Scale bar, 30m.B, Vestibular ganglion
of B/mouse shows the same inclusionbodies as the cochlea SGbutwith less degeneration fromP8mo toP15mo. Scale bar, 30m.C, RepresentativeVsEP intensity series forWT (left) andB/
(right)mice. The first two positive response peaks are labeled P1 and P2, respectively. Stimulus levels are shown in decibels (re: 1.0 g/ms) and ranged from6 dB to18 dB. At6 dB, VsEPswere
collected without the forward masker (UM) and later with the masker (M) throughout the testing. Each stimulus level shows two response waveforms to demonstrate response replication. As the
stimulus level is reduced, peak-to-peak amplitudes decrease and latencies increase until no response is observed at levels below threshold. VsEP thresholds for these representative animals were
scored at13.5 dB re: 1.0 g/ms for WT and absent response for B/. Total time represented for each waveform is 10ms. D, Representative VsEP waveforms recorded at themaximum stimulus
level (6 dB re: 1.0 g/ms) for three WT (top) and three B/ (bottom) mice. WT mice showed normal vestibular function, and VsEPs were completely absent from B/ mice. The first two
response peaks are labeled P1 and P2, respectively. Two waveforms are shown for each animal to demonstrate response replication. Total time represented for each waveform is 10 ms.
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lation of sulfatides could decrease galactosylceramide, but cer-
amides may not be affected because their levels can be balanced
from sphingomyelin and glucosylceramide pathways. Further, it
has been previously reported that galactosylceramide is not sig-
nificantly altered in the sap B-deficient mouse brain (Sun et al.,
2013) and ceramide is also not altered. Thus, the results in the ear
conform towhat was seen in the brain. Paralleling the progressive
sulfatide accumulation was satellite cell degeneration starting af-
Figure 7. Liquid chromatography/mass spectrometry analysis of sulfatide levels in B/ cochlear SGs. A, Significant alcian blue staining of the B/ cochlear SGs (blue stain) is seen when
compared with the WT cochlear SGs, indicative of sulfatide accumulation in SG neurons of B/ mice. The whole cochlear section (top, low magnification; scale bar, 200 m) and a higher
magnification of the SGs (bottom; scale bar, 50m) are shown.B, Most of the NFA sulfatide (top) andHFA sulfatide (bottom) specieswere increased in B/mouse SGs comparedwithWTmouse
SGs. Total NFA sulfatides and HFA sulfatides were increased in B/ mouse SGs by 1.74-fold and 1.44-fold, respectively, when compared with that of WT mice SGs. C, C18 ceramide and total
ceramides show no significant increase in the B/ SGs when compared with that of WT SGs. D, Most NFA sulfatides are increased when normalized to C18 ceramide in the same sample. E, Most
HFA sulfatide species are also significantly increased when normalized to C18 ceramide in the same sample. Total sulfatides in B/ SGs were increased by 1.65-fold compared with WT SGs,
mirroring the increased alcian blue staining on SGs in cochlea (A).
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ter P4mo. These changes mirror those seen not only in the ASA-
deficient mice but also in pathologic specimens from humans
with MLD (Hess et al., 1996).
While the overall pattern of SG degeneration seen in B/
mice resembled that seen in ASA-deficient mice, the latter
showed more severe alterations of SG neurons at a much earlier
time point, between 4 and 8months (Coenen et al., 2001). Similar
milder findings have been noted for other organs in B/ mice
comparedwithASA-deficientmice (Sun et al., 2008). Reasons for
these differences are unknown. However, one possible reason
could be a lack of alternative ASA-independent pathways for sul-
fatide metabolism (Sundaram et al., 1995). Another possible rea-
sonmay have to dowith Sap B deficiency, whichmay result in the
accumulation of fewer GSLs than in ASA-deficientmice. It is also
possible that despite undetectable levels of Sap B, there may be
some residual Sap B function based on the nature of themutation
(absence of the disulfide bond). However, we feel this is unlikely
given the dependence on this bond for function, and given evi-
dence from prior studies demonstrating lack of Sap B activity in
this model. Comparative quantitative analysis of sulfatide accumu-
lation between these two models could help answer this question.
The pattern of hearing loss contrasting the ASA-deficient and the
B/micemirrored themorphologic differences seen. In the ASA-
deficient mice, the loss of ABR threshold shifts occurred at an
earlier age, was more severe, and closely paralleled the deteriora-
tion of the SG cells and nerve fibers (D’Hooge et al., 1999). For
example, in the B/mice, at P15mo, with	15% survival of the
cochlear SG neurons, the click ABR threshold increased by 15 dB;
by comparison, the ASA-deficient mice lost most of their SG cells
and had absent ABR thresholds by this same age (Hess et al., 1996).
Another important finding in this study was in the nature of
the changes to themyelin sheath of the SG neurons. As evidenced
by light microscopy and EM (Figs. 1, 3), the myelin surround the
degenerating SG neurons in the B/mice were either absent or
quite thinned (Figs. 1C, 3A,B). In contrast, in the cochlea of
ASA-deficient mice, the degenerating spiral perikarya and axons
were surrounded by intact satellite and Schwann cells and struc-
turally normal myelin sheaths (Coenen et al., 2001). Sap B thus
appears to play a more critical role in the maintenance of the
myelin sheath than ASA in these neuronal subtypes. Further,
most of the surviving neurons in the older B/mice proved to
be small, primarily nonmyelinated type 2 ganglion cells, which
are known to represent a small minority (5–10%) among the SG
cells of normal animals (Jagger and Housley, 2003). The small
diameter and the absence of a compact myelin sheath served to
identify these surviving neurons as type 2 cells (Fig. 1C, P15mo,
arrowheads).
Interestingly, despite severe progressive neuronal degenera-
tion seen in these B/ mice, all measures of efferent function
were normal, including DPOAEs, CS-DPOAEs, and OHC
counts, through P8mo (Fig. 5). Themedial olivocochlear (MOC)
efferent auditory neurons are myelinated, while the lateral olivo-
cochlear (LOC) neurons are not (Liberman and Brown, 1986).
Thus, one would expect, if similar degenerative phenomenon
were occurring in this system, that the MOC system would be
impaired while the LOC would be intact. The intact efferent re-
sponse thus suggests several possibilities: the efferent systemmay
bemore robust than the afferent neuronal system to loss of Sap B,
and/or efferent neurons employ alternative metabolic pathways
for GSL metabolism that allowed them to be spared the changes
seen with the afferent system. Along similar lines, the dorsal root
ganglia in B/ mice and other Sap KO mice have also been
noted to have inclusions, but motor neurons are generally not
affected by these changes (Sun et al., 2007, 2008), again suggest-
ing alternative manifestations of Sap function in afferent versus
efferent neurons.
It is interesting to note that in contrast to the striking histo-
logical changes seen in the B/ mouse, ABR threshold shifts
were mild initially and did not progress until much later in the
disease process. At P4mo, ABR thresholds demonstrated no sig-
nificant differences among the B/, Het, and WT mice (Fig.
4A), at a time when SG degeneration was beginning and the
satellite cell inclusions were developing. By P8mo, however (Fig.
4B), a significant increase of ABR thresholds was observed for
each of the tone-burst stimuli (8, 16, and 32 kHz), though signif-
icant shifts in ABR click responses were not seen until P13mo
(Fig. 4C). This overall preservation of click responses in the face
of significant neuronal degeneration until the most advanced
stages of decline mirrors results seen in mouse models of hearing
recovery after noise exposure (Kujawa andLiberman, 2009; Lin et
al., 2011), inwhicheven“reversible”noise exposurewith recoveryof
auditory thresholds leads to long-term afferent nerve terminal de-
generationwhile retaining “normal” auditory thresholds. A similar
phenomena was observed in a previous study involving virally
mediated hearing rescue in the vesicle glutamate transporter 3
KO (VGLUT3 KO) mouse (Akil et al., 2012). In these studies,
viral delivery at postnatal day (P) 10–P12 caused VGLUT3 ex-
pression in only 40% of IHCs, yet this was enough to restore ABR
thresholds to WT levels for click responses and to near normal
levels for pure-tone thresholds. These and similar studies further
support the notion that the ABR threshold analysis is an incom-
plete measure of cochlear health.
Last, we observed a large discrepancy between the phenotypic
and physiologic effects from the loss of Sap B function in the
vestibular system. The general structure of the vestibular gan-
glion was slightly altered in the B/mouse with less damage to
Scarpa’s ganglia neurons, despite the presence of similar inclu-
sion bodies that were seen in SG satellite cells (Fig. 6B). Despite
thesemild changes, VsEPs documented a complete loss of vestib-
ular function. The nature of this discrepancy remains unclear. It
is known that a variety of lesions to the inner ear, including dam-
age from surgical, acoustic, or ototoxic trauma, often affects the
cochlea to a greater degree than the vestibular system (Spoendlin,
1975; Hoeffding and Feldman, 1988). However, in many of these
models, it is the hair cells and supporting cells that are initially
damaged, followed by secondary neuronal degeneration, whereas
in the B/mice, these former structures are all normal. Again,
the apparent vulnerability of themyelinated SGneurons to loss of
Sap B functionmay be playing a role here. As noted by Spoendlin
(1971), transection of the vestibular-cochlear nerve leads to the
degeneration ofmyelinated SG neurons and the survival of type 2
SG neurons, the organ of Corti, and the vestibular ganglion. This
implies that the phylogenetically older vestibular ganglion neu-
rons are not as sensitive to changes in myelin metabolism. An-
other clue comes from comparisons with the ASA-deficientmice,
where the storage material did accumulate in the vestibular hair
cell, andwas accompanied by degeneration of vestibular ganglion
neurons (Coenen et al., 2001), whereas in the B/mice here, the
vestibular epithelium was intact and the storage material was not
seen accumulating in the vestibular hair cells.
Conclusion
Sap B is an essential activator protein for ASA in the hydrolysis of
sulfatide, a critical lipid component of myelin. Within the ear,
though deficiency of Sap B leads to sulfatide accumulation in
satellite cells, causing SG and vestibular ganglion degeneration,
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only the myelinated SG neurons undergo large-scale neuronal
degeneration, in turn leading to hearing loss and vestibular dys-
function. Nonmyelinated fibers in the SG are spared, preserving
the efferent system. Our findings show that Sap B deficiency,
though not as severe as a deficiency of ASA, nonetheless mimics
the pathologic changes seen in human MLD-related diseases.
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